Business Daily Media

The Times

.

Eisai and Seikagaku Enter into Agreement for the Marketing Alliance of SI-613, a Treatment of Osteoarthritis, in South Korea

  • Written by ACN Newswire - Press Releases

Eisai and Seikagaku Enter into Agreement for the Marketing Alliance of SI-613, a Treatment of Osteoarthritis, in South Korea

TOKYO, Sep 30, 2020 - (JCN Newswire) - Eisai Co., Ltd. and Seikagaku Corporation announced today that the companies have entered into an agreement for the marketing alliance in South Korea for SI-613 (diclofenac conjugated sodium hyaluronate), a therapeutic agent for osteoarthritis discovered by Seikagaku. Eisai and Seikagaku signed an agreement

Read more //?#

Why self-service is reshaping fleet management for modern businesses

Fleet management today is constrained by fragmented systems and heavy administrative demands. A lot of the work still relies on booking vehicles and...

Fraud Prevention and security crucial as identity crime hits record highs in Australia

In a radically transformed risk landscape where the scale and speed of financial fraud have reached unprecedented levels, Australian businesses ar...

Sectorial ATO Tax Debt Disclosures Rise, Overall Business Credit Demand Flattens and High-Risk SME 'Credit Shopping' hits 8-month peak

Q1 2026 Equifax Business Market Pulse shows low-risk borrowers consolidate demand enquiries while sub-prime entities accelerate shopping activity ...

SME support in Federal Budget falls short of easing business pressures

“The Federal Budget delivered several measures aimed at supporting small businesses, including making the instant asset write-off permanent, exten...

Bunji dog treats to hit Ritchies shelves

Cooee Native Superfoods’ Bunji range of dog kibble and treats is rolling out across Ritchies Supermarkets now, with stock already on shelves in se...

Pre-Budget Expectations

“Australian corporates and SMBs are under pressure. Competition from global players is intensifying, margins are under strain, and technology adop...